The French-American-British group proposed the classification of erythroleukemia as acute myelocytic leukemia (AML) M6 (1) . This definition is based on the association of an erythroblastosis comprising over 50%of the nucleated bone marrowcells and an excess of non-erythroid blast cells. However, this definition is restrictive because the content of erythroblastosis is heterogeneous according to the differentiation level of abnormal erythroblasts.
Recently, minimally differentiated erythroleukemia (AMLM6'variant') was proposed as a rare subset of AMLdistinct from AMLM6by Garand et al (2) . When immunophenotyping leukemic cells, they had a HLA DR" CD36++ B" T myeloid" (0033*) immunophenotype in addition to a proerythroblast-like or an undifferentiated morphology. The morphological features of the latter sometimes lead to an initial diagnosis of an undifferetiated acute leukemia or a minimally differentiated AML(AMLMO) (3), before studying the erythroid markers on leukemic cells. Such cases as minimally differentiated erythroleukemia have been reported previously and designated as ' cryptic erythroleukemia' (4) or ' early erythroblastic leukemia' (5). Villeval et al (5) distinguished two main phenotypes that correspond to discrete stages of the normal erythroid differentiation:
A) the phenotype is identical to that of an immature erythroblast which expresses glycophorin A (GPA) identified by monoclonal antibody. B) the phenotype is related to that of CFU-Ewhich expresses carbonic anhydrase I (CAI) (6, 7), CD36 (8, 9) andA antigen, but not HLA-DRantigen. Clinically, it is interesting that minimally differentiated erythroleukemia may arise as de novo AML,in Down'ssyndrome,as myelodysplastic syndrome-related AML or as blastic crisis in chronic myelogenous leukemia (2, 4, 5). At present, there are manytechniques which enable the recognition of erythroid precursors and progenitors: e.g. , immunophenotyping with erythroid-specific monoclonal antibodies, ultrastructural detection of ferritin molecules (10, 1 1), in vitro colony assay and molecular techniques studying mRNAexpression of a-or y-globin, erythroid-specific 8-amino-levulinate synthethase and GATA-1 transcription factor genes ( 12-14). GPA,band 3, and spectrin are specific membranecomponents of mature erythrocytes. Loken et al (15) See also p 843.
In detail, they reported the relationship between Tn and sialosyl-Tn antigens and the differentiation of erythroid progenitors and precursors in another manuscript (24). In the future, erythroid-specific markers and differentiation markers of erythroid cells will likely be arranged according to their specificity and convenience and the differences between normal and leukemic erythroid precursors and progenitors would also be clarified. Blood 83: 84-91, 1994.
